ABSTRACT Our knowledge of how bioactive lipids participate during development has been limited principally due to the difficulties of working with lipids. The availability of some of these lipids is regulated by the Lipid phosphate phosphatases (LPPs). The targeted inactivation of Ppap2b, which codes for the isoenzyme Lpp3, has profound developmental defects. Lpp3 deficient embryos die around E9.5 due to extraembryonic vascular defects, making difficult to analyze its participation in later stages of mouse development. To gain some predictive information regarding the possible participation of Lpp3 in later stages of development, we generated a Ppap2b null reporter allele and it was used to establish its expression pattern in E8.5-13.5 embryos. We found that Ppap2b expression during these stages was highly dynamic with significant expression in structures where multiple inductive interactions occur such as the limb buds, mammary gland primordia, heart cushions and valves among others. These observations suggest that Lpp3 expression may play a key role in modulating/integrating multiple signaling pathways during development.
Introduction
Participation of bioactive lipid-mediated signaling in the regulation of a wide variety of cellular processes has gained extensive attention during the past two decades. However our knowledge on the contribution of lipid-mediated signals to developmental processes has progressed slowly. Most of the information regarding bioactive lipid participation during development has arisen from studies involving the use of inactivating mutations of their receptors and/or their synthesizing or metabolizing enzymes (Brindley, 2004 , Mizugishi et al., 2005 , Saba, 2004 , Tanaka et al., 2006 , van Meeteren et al., 2006 .
Lipid phosphate phosphatases (LPPs) are a group of integral membrane enzymes that participate in intracellular lipid metabolism. Moreover, they regulate the biological activity and signaling of several bioactive phospholipids such as phosphatidic acid (PA), diacylglycerol (DAG), lysophosphatidic acid (LPA), sphingosine-1-phosphate (S1P), ceramide-1-phosphate (C1P) and ceramide (Brindley et al., 2002, Brindley and Waggoner, 1998) controlling the availability of their phosphorylated substrates and Int. J. Dev. Biol. 53: 139-147 (2009) (Jia et al., 2003 , Kai et al., 2006 , Sciorra and Morris, 1999 , Sigal et al., 2005 , Sun et al., 2004 . Intracellular LPPs control the balance between PA and DAG therefore alter cell signaling mediated by these lipids and the synthesis of choline-and inositol-containing phospholipids. They play a fundamental role in the hydrolysis of phospholipase D (PLD)-derived PA and, in consequence, modulate PLDmediated signaling. Some of the targets of PLD-derived PA are PI4PK, Sos, Raf and mTOR while RasGRP1 is regulated by LPPderived DAG (McDermott et al., 2004 , Mor et al., 2007 , Zhao et al., 2007 . A role in the regulation of the intracellular pools of other lipids has been demonstrated for S1P (Long et al., 2005) although involvement in the conversion of C1P to ceramide is also possible. LPPs localized in the plasma membrane serve to attenuate the receptor-mediated signaling of extracellular LPA and S1P, which in turn activate a wide variety of signaling pathways such as PLC/ Ca ++ , Ras/ERK/MAPK, Rac, Rho and PI3K (Brindley, 2004 , Moolenaar et al., 2004 , Pyne et al., 2004 . Furthermore, biological actions independent of their catalytic activity have been proposed for some LPPs (Escalante-Alcalde et al., 2003 , Humtsoe et al., 2003 , Zhao et al., 2005 .
Most of the information regarding the participation of LPPs in specific cellular processes has stemmed from in vitro experiments. However, research performed during the last ten years has demonstrated their important contribution to development. In Drosophila, wunen and wunen2 are required for proper germ cell migration and survival (Hanyu-Nakamura et al., 2004 , Renault et al., 2004 , Starz-Gaiano et al., 2001 , Zhang et al., 1997 . Furthermore, wunen also participates in proper neuron synaptogenesis and in the establishment of intestinal left-right laterality (Kraut et al., 2001 , Ligoxygakis et al., 2001 . Additionally lazaro is involved in the turnover of phosphatidylinositol during the process of phototransduction (Garcia-Murillas et al., 2006) . In the mouse, out of the three Lpps identified, Ppap2c/Lpp2 null-gene inactivation and a gene trap of Ppap2a/Lpp1 are viable and fertile without any apparent phenotype (Zhang et al., 2000, Lynch, pers comm.) . In contrast, Ppap2b/Lpp3 targeted inactivation results in profound developmental defects indicating the essential participation of Lpp3 in mouse embryo development. Lpp3 deficient embryos die around E9.5 due to extraembryonic vascular defects. With lower penetrance, earlier lethality is due to anterior-posterior patterning alterations related to the antagonistic effect of Lpp3 on the Wnt/ β-catenin signaling pathway by a still poorly understood mechanism (Escalante-Alcalde et al., 2003) .
The early embryonic lethality of Lpp3 deficiency makes difficult the analysis of its participation in later stages of mouse development. One way to gain some predictive information regarding the possible participation of Lpp3 in later stages of development is through the detailed analysis of its expression pattern. In this study we describe the generation of a Ppap2b null reporter allele, which was used to establish its expression pattern in E8.5-13.5 embryos. Remarkably, Ppap2b expression during these stages was highly dynamic with significant expression in structures where multiple inductive interactions occur such as the limb buds, mammary gland primordia, heart cushions and valves among others.
Results
Despite the wide range of available information in databases regarding mRNA expression using microarray analysis, little is known about the tissue-specific expression pattern of Lpp3 during development. Here we describe the generation of a reporter null allele of Ppap2b by inserting the bacterial β-galactosidase gene (lacZ) in exon 3 (Fig. 1) by homologous recombination in embryonic stem (ES) cells, which was designated Ppap2b tm2Stw . For convenience, we will refer to this allele as Ppap2b lacZ . Heterozygous Ppap2b lacZ mice were viable and fertile. Mating of heterozygous Ppap2b lacZ on either 129/SvJ x C57BL/6J or a pure 129Sv/ J background yielded animals only of wild type and heterozygous genotype indicating that this allele is embryonic lethal (57% +/-; 42% +/+; n= 218). The phenotype of homozygous Ppap2b lacZ embryos from heterozygous intercrosses, was essentially identical to our formerly described null alleles Ppap2b tm1Stw and Ppap2b tm3.1Stw (Escalante-Alcalde et al., 2003 , Escalante-Alcalde et al., 2007 . This was characterized by a delay in development when compared to wild type or heterozygous littermates (12 to 24 hours), absence of chorioallantoic fusion at the 6 somite stage, allantois compaction ( Fig. 1E-F) , impaired remodeling of the primary capillary plexus of the yolk sac and gastrulation defects with low penetrance (not shown). Furthermore, in the bestdeveloped mutant embryos, persistence of open neural tube was frequent (Fig. 1G) . The use of an IRES sequence in the targeting design allowed us to detect the endogenous transcriptional activity of Ppap2b. Intensity of β-galactosidase staining recorded before embryo death, correlated with the genotype being more intense in homozygous than in heterozygous embryos. The expression of Ppap2b during early mouse development (E6.5-E8.5) using this allele has been shown previously (EscalanteAlcalde et al., 2003) . In this work we described, in detail, the expression pattern of Ppap2b in E8.5-E13.5 embryos to gain some predictive information regarding the participation of Lpp3 during these developmental stages. We used heterozygous embryos to reveal Ppap2b expression as reported by the activity of β-galactosidase (β-gal) and compare these patterns with those obtained by whole mount in situ hybridizations and in some stages by whole mount immunohistochemistry to test the fidelity Figures 2 and 4 , mRNA, protein and β-gal expression patterns were essentially identical with few differences in β-gal intensity (likely due to its stability) and to the amount of Lpp3 protein in some neural structures (see below). As discussed in the following section, due to the great sensitivity of this reporter, we detected structures showing even low levels of Ppap2b expression. Cells expressing low-expression levels showed one (or a few) cytoplasmic granule while cells expressing higher levels of the enzyme showed a more homogeneous cytoplasmic staining.
Expression of Ppap2b in E 8.5 mouse embryos
In embryos Theiler stages (TS) 12-13, Lpp3 expression was abundant in the allantois and paraxial mesoderm but absent or weak in the forebrain and posterior embryonic domain respectively ( Fig. 2A-B ). Cells expressing β-gal were more abundant in the head and cervical mesoderm. The pericadial-peritoneal mesothelial cells and the somites showed conspicuous staining ( Fig.  2C-E ). β-gal activity was detected in cells along the gut endoderm being more intense at the level of the foregut diverticulum entrance ( Fig. 2C-D) . Expression was detectable in the neuroepithelium such as in the prospective midbrain, hindbrain and the ventral portion of the future spinal cord (Fig. 2 B-E). Furthermore, β-gal was expressed in the notochord (Fig. 2E ) and in the region where it is organized at the level of the primitive streak. Reporter activity was found in the amnion and at lower activity in the visceral endoderm and vascular mesodermal cells of the yolk sac (not shown).
Expression of Ppap2b in E9.5 mouse embryos
In TS 14, regions exhibiting the strongest expression levels were the endoderm and ectoderm epithelia of the future tympanic membrane region followed by the allantois, somites, paraxial tissue at the cervical region and the developing intraembryonic coelomic cavity area ( Fig. 2F-G) . Sections through the embryos showed expression in the cephalic and cervical mesenchymal cells ( Fig. 2H ) with the exception of the mesenchyme in the telencephalic area. The otic vesicle epithelium and migratory neural crest tissue showed detectable expression (not shown). In the heart, cells in the wall of the outflow tract (Fig. 2I) , the posterior wall of the common atrial chamber and few cells of the endocardial lining in the bulbo-ventricular canal showed reporter activity. Along the gut, expression was variable, with higher levels in the thyroid primordium, the ventral aspect of the foregut endoderm and lower levels present in the hepatic diverticulum, at the foregut-midgut junction and hindgut diverticulum ( Fig. 2I-J) . The strongest intraembryonic expression was in the mesothelial cells forming the pericardial-peritoneal coelomic cavity at the level of the developing forelimb (Fig. 2J) . Expression in the notochord and developing nervous system followed the same expression pattern In some cases, strong β-gal staining is clearly observed in blue or purple color (N-P). a, allantois; ba, 1 st branchial arch; cm, coelomic mesothelium; cr, cervical region mesoderm; da, dorsal aorta; dm, dorsal mesentery; dmy, dermomyotome; drg, dorsal root ganglion; f, forebrain; fd. foregut diverticulum; fg, foregut epithelium; fl, forelimb; fp, floor plate; GnV, trigeminal ganglion; hc, heart cushions; hd, hepatic diverticulum; hm, head mesenchyme; me, mesoderm; m/h, midbrain/ hindbrain region; mn, motor neurons; n, notochord; nt, neural tube; otr, outflow tract; ov, otic vesicle; ppc, pericardial-peritoneal canal; psm, presomitic mesoderm; s, somite; t, thyroid primordium; tm, future tympanic membrane; ugc, urogenital crest; Viii, acoustic neural crest cells. as in the previous stage (Fig. 2H) . In TS 15 embryos forelimb buds showed a strong β-gal staining in a group of scattered ectodermal cells in the ventral side of the developing forelimb (Fig. 3A) .
Expression of Ppap2b/Lpp3 in E10.5 mouse embryos
In embryos TS 18, reporter activity was broadly found in the mesenchyme. In the cephalic and cervical regions, expression in the cephalic flexure mesenchyme and the one surrounding the primary head and anterior cardinal veins and dorsal aorta was more intense (Fig. 2K-L, N-P) . Expression was also found in the mesenchyme of the anterior-distal aspect of the maxillary component of the first branchial arch and the second branchial arch (Fig.  2L ). In the paraxial mesenchyme, expression was more abundant in the anterior (Fig. 2S ) than in the posterior part (Fig. 2T ) of the embryo correlating with de-epithelization of the somites into sclerotome cells. Expression in the dermomyotome of epithelialized somites was present in the caudal region whereas at the cervical and thoracic levels, expression was gradually restricted to the dorsal lip region of the dermomyotome (Fig. 2L) . Expression in the notochord was more evident at this stage (Fig. 2S) .
Staining in the heart area corresponded to the most dorsal aspect of the heart and the body wall overlaying the pericardial cavity. Detectable expression was found in the endocardial cushion tissue associated to the atrioventricular canal and in cells of the dorsal truncus arteriosus (Fig. 2Q) . At this stage, expression in blood vessel endothelial cells was evident. The dorsal mesocardium as well as the mesenchyme surrounding the bronchus epithelium and oesophageal region of the foregut showed moderate β-gal activity (not shown). In the urogenital area, a bilateral stripe of mesothelial cells contiguous to the dorsal mesentery and the mesenchyme adjacent to the dorsal aorta showed reporter activity (Fig. 2T) .
Expression was also detected in some components of the central and peripheral nervous systems at this stage. Forebrain neuroepithelium was devoid of significant reporter expression.
indicated the future digital domains of the forelimb (Fig. 3D) . Expression of β-gal in the developing mammary gland placodes 3 and 4 was evident at this stage ( Fig.  3D) . At the hindlimb level, the paraxial mesenchyme ventral to the inter dorsal root ganglia space expressed abundant reporter activity. Expression in the urogenital sinus area and umbilical hernia was stronger than in previous stages. Dermal expression in the cervical area became evident at this developmental stage.
Expression of Ppap2b in E12.5 mouse embryos
In this stage, expression in the dermis had extended and the five pairs of mammary gland placodes showed abundant Lpp3 expression. The head mesenchyme showed abundant expression being more evident around the primary head vein and the cephalic ganglia. Ppap2b/ Lpp3 expression was detected in the most ante- Fig. 2M -P) while a group of presumptive motor neurons showed reporter activity at the thoracic and lumbar areas (Fig. 2R) . In the eye, detectable expression was found in the central domain of the outer layer of optic cup and lens pit (not shown). Ppap2b was also expressed in neural crest derivatives. In the trigeminal crest tissue, facio-acoustic (VII-VIII) neural crest complex and other developing cervical ganglia, expression was evident in certain groups of cells ( Fig. 2O-P) . Stronger expression levels were observed in the interacting region between the otic vesicle epithelia and the neural crest cells of the acoustic preganglion (Fig. 2P) . The dorsal root ganglia showed a low but still detectable activity of β-gal. Unexpectedly, in contrast with the level of β-gal activity found in neural derivatives, Lpp3 immunohistochemistry showed a very strong staining in projecting axons of cranial ganglia and motor neurons. Furthermore, a weak expression in the ependyma of the spinal cord was evidenced (Fig. 4H ).
In the limbs, the apical ectodermal ridge (AER) is the structure with strongest expression of Ppap2b at this stage. In the forelimbs moderate expression was found in the progress zone (PZ) region and the proximal dorsomedial mesenchyme, though expression in the PZ area was more restricted to the dorsal side (Figs. 3B-C,  4I ).
Expression of Ppap2b/Lpp3 in E11.5 mouse embryos
Ppap2b expression pattern was essentially the same as that observed in E10.5. However, modification in the expression pattern of some structures was observed. Expression in the AER of limbs was preserved though weaker staining was observed in the superficial dorsomedial mesenchyme of the zeugopod. A region expressing strong reporter activity was present in the dorsal-central domain of the autopod and a weak expression showing Lpp3 expression in a group of dorsal interneurons (in), the ependymal layer (ep), a subset of motor neurons (mn), dorsal root ganglion (drg) and projecting axon (ax). m, myotome; mg, mammary gland. In earlier embryos (E10.5), expression of Lpp3 protein in neural derivatives (H) such as the fasiculated axons (fax) projecting to the cervical or forelimb areas is also more evident by immunohistochemistry. Insert: transverse section at the level indicated by the white dashed line. In contrast, expression in non-neural tissue is essentially identical to the expression pattern obtained using the reporter allele. For instance, in the limb buds (I), staining was found in the apical ectodermal ridge (AER) and progress zone mesenchyme (pzm) of the forelimb (fl). hl, hindlimb.
G B C D E F H I
A rior myotomes at the inter limb area and more restricted to their dorsal lip in the rest of the embryo (Fig. A-B and D-E). Expression was found in the tail somites but absent in its distal extremity. The liver and heart did not show significant Ppap2b expression except for the atrioventricular endocardial cushions (not shown). In the genitourinary system, expression was found in the mesonephric ducts epithelium and urethral plate epithelium in addition to the deep mesenchyme of the genital tuberculum (not shown).
In the CNS, expression in the central domain of the optic cup was preserved however reporter activity in the optic stalk and developing hyaloid plexus was apparent at this stage (not shown). Expression domains in the ventral midbrain, hindbrain, spinal cord and peripheral structures were essentially as in the previous stage, but new expression domains became apparent by immunostaining, such as a group of spinal dorsal interneurons ( Fig. 4C and G). Weak expression levels were also detected in the infundibulum neuroepithelium and the thalamus ventricular area. A graded expression of β-gal was observed in dorsal root ganglia being stronger in posterior than in anterior ganglia.
Expression in the AER was gradually down regulated between E11.5 and E12.5. While expression in the AER disappeared, expression in the mesenchyme surrounding the marginal vein was evident but stronger in the distal region of the prospective digits. The dorsal central domain of expression in the autopod was wider. Expression in the dorsal muscle anlagen was evident in the developing limbs (Fig. 3E, 4A-B) .
Expression of Ppap2b in E13.5 mouse embryos
β-gal expression was widely distributed at this stage. However, reporter activity in the surface ectoderm, in most of the endodermderived epithelia, liver, heart muscle, condensed cartilage and the follicles of vibrissae, was very low or undetectable (Fig. 5) . In the heart, the developing atrioventricular valves, atrium and vena cava showed reporter activity (Fig. 5 C-F) . β-gal staining varied from strong to moderate in the perichondrium tissue and in some regions of highly differentiated cartilage (Fig. 5C, F-G) . In the limbs, expression was found in the perichondrium of developing skeletal elements, the most central cells of the developing digits and the tip of the digits (Fig. 3F-G) . Expression was also evident in the dorsal and ventral muscle anlagen (not shown) and developing ventral tendons (Fig. 3F) . The mammary gland epithelia showed strong reporter activity while in the surrounding mesenchyme was weaker ( Fig. 3G-H, 4A ). In the brain, β-gal expression was restricted to some structures such as the developing cerebral cortex and the ventricular area of the mesencephalon, rhombencephalon and cerebellum primordium ( Fig. 5C and data not shown) . In the spinal cord, a stripe of β-gal positive cells running along the central domain of the ependymal layer was observed and a weaker staining extended to the whole ependymal layer (Fig. 5H-I ). Dorsal root ganglia showed a low but still detectable level of reporter activity (Fig. 5C , F and H).
Discussion
The mouse Lpp3 belongs to a group of enzymes with the potential to regulate/modulate a wide variety of signaling pathways. This would initially suggest a ubiquitous expression for this enzyme. Nonetheless, our previous (Escalante- Alcalde et al., 2003) and present data show that, Lpp3 displays a very dynamic and specific expression pattern during mouse embryo development.
Our analysis revealed that the reporter allele clearly reflected the endogenous mRNA expression pattern however the amount of Lpp3 protein did not correlate with the relative transcription levels found in central and peripheral nervous structures. For instance, in dorsal root ganglia or the motor neurons in the spinal cord, while the β-gal activity or amount of mRNA were very low, protein levels were much more robust. Furthermore, the protein content in developing nerves from motor neurons, cranial and dorsal root ganglia was particularly abundant (Fig. 4C, F-H) . This observation suggests a tissue-specific translational regulation of Lpp3 in the nervous system.
Interestingly Ppap2b/ Lpp3 expression is abundant in sites where multiple inductive interactions occur such as the limb bud, mammary gland and developing heart valves. In these structures, the convergence of several signaling pathways takes place to give rise to proper development and patterning. In the limb bud, FGF signaling from the AER is fundamental for proper proximal-distal limb patterning and development (Sun et al., 2002, Yu and Ornitz, 2008) . Lpp3 is abundantly expressed in the AER between E9.5 -E12.5, fingertips at E13.5 and in the distal mesenchyme around E10.5. It would be interesting to analyze whether expression of Ppap2b in the AER is a consequence of Fgf8 signaling. Furthermore, it is temping to speculate that Lpp3 could function as a modulator of Fgf8 signaling in the AER and subjacent mesenchyme in view of its potential impact on Ras activation, through the control of phosphatidic acid and DAG levels. On the other hand, Wnt7a non-canonical signaling from the dorsal ectoderm and Engrailed-1 activity from the ventral ectoderm are both required for D-V limb patterning. While Wnt7a induces Lmx1b expression in the dorsal mesenchyme, β-catenin-induced En1 expression in the ventral ectoderm is required to restrict Lmx1b expression in the ventral mesenchyme (Loomis et al., 1996 , Loomis et al., 1998 . It is worth noting that Lpp3 is expressed in the distal-dorsal limb mesenchyme at E10.5 partially resembling the Wnt7a-dependent expression of Lmx1b in the limb. It will be interesting to determine whether Lpp3 expression in dorsal domains of the limb is downstream of Wnt7a/Lmx1b and whether it participates in dorsalventral and proximal-distal limb patterning.
Ppap2b expression is very abundant in epithelial placodes and mammary buds at E11.5-13.5 embryos. Moreover, it appears progressively in the surrounding mesenchyme after E13.5 while epithelial expression gradually diminishes in E15.5-16.5 (not shown). In the mouse embryo, mammary gland specification is dependent on FGF signals from the ventral-lateral dermomyotome at the level of the milk line and Wnt signals in the milk line ectoderm. Posterior placode formation requires the participation of the same groups of factors but more prominently of Wnt signals (Hens and Wysolmerski, 2005) . Contradicting results regarding the participation of epithelial or mesenchymal Wnt signals during mammary bud development exist, using two different TOPGAL reporter transgenics. In one study, β-gal activity was found first in ectodermal cells along the mammary line and latter restricted to epithelial cells of the mam- d, dorsal; di, diaphragm; drg, dorsal root ganglion; h, heart; hindbrain li, liver; lu, lung; mg, mammary gland buds; nt, neural tube; pi, pituitary; r, rib cartilage primordium; tg, tongue; v, ventral; vc, vena cava; ve, vertebral cartilage primordium; vs, vibrissae follicles; vz, ventricular Chu et al., 2004) . In the other, β-gal expression in the mesenchyme surrounding the mammary placodes started around E11.5 and it was not until E13.5 that it was also found in the bud epithelia, all of these in agreement with nuclear localization of β-catenin (Boras-Granic et al., 2006) . The latter work suggests that mesenchymal cells integrate Wnt signals during the early stages of mammary gland development and that epithelial Wnt expression is required later to the progress of mammary gland development. We have previously described that Lpp3 acts as a negative regulator of the canonical Wnt/β-catenin signaling pathway (Escalante-Alcalde et al., 2003) . In this sense, Ppap2b expression during mammary gland development fits better with the second model where it acts as a negative feedback loop to attenuate canonical Wnt signaling, by restricting Wnt activity in epithelial cells during early mammary gland development and then to restrict Wnt activity in the surrounding mesenchyme. Ppap2b expression during cardiac valve development was particularly interesting. Abnormalities in heart valves and associated structures are the most common subtype of cardiovascular malformation. Heart valves develop from cardiac cushions produced by endothelial-mesenchymal transition of the endocardial cells with subsequent proliferation and tissue remodeling in specific regions of the heart. Cushions later protrude from the underlying myocardium to form the valve leaflets (Armstrong and Bischoff, 2004, Lincoln et al., 2004) . A complex signaling network involving Vegf, Nfat, Notch, Wnt/β-catenin, BMP, TGFβ, ErbB and NF1/Ras has been implicated in the control of heart valve development (Armstrong and Bischoff, 2004) . Again, due to the potential effect of Lpp3 in modulating several of these signaling pathways, an essential role for it in heart valve development may be predicted.
During central and peripheral nervous system development, Ppap2b/ Lpp3 is expressed in a very particular fashion. In the central nervous system, Lpp3 is present predominantly in ventral domains of the neural tube as early as E8.5. In addition it is remarkable that Ppap2b is expressed in the notochord. Gene expression and cell type specification in ventral domains of the neural tube are mainly controlled by the secretion of Shh by the notochord and floor plate . In this sense, it is provocative to speculate that Lpp3 expression in the neural tube, notochord and perhaps paraxial mesenchyme (see below) might be regulated by Shh signaling. In support of this idea, an in silico analysis (NCBI DCODE.org Comparative Genomics Developments) of conserved regulatory elements in the Ppap2b promoter of rat and mice, revealed the presence of putative binding sites for Gli2, Pax6, Nkx2-2, Nkx6-1 and FoxA2 transcription factors, all participating in the ventral specification of the neural tube (Briscoe et al., 1999 , Ding et al., 1998 , Ericson et al., 1997 , Sander et al., 2000 , Sasaki et al., 1997 . Assaying whether inhibition of Shh signaling affects the neural expression of Lpp3 and whether the aforementioned putative binding sites are functional will be of significance. Furthermore, it will be interesting to analyze the participation of Lpp3 in the specification of ventral cell types in the neural tube. Up-regulation of Ppap2b expression by the treatment with Shh has been recently described in mesenchymal stem cells (Ingram et al., 2008) .
As shown, Lpp3 is also abundantly expressed in projecting axons of motor neurons, cranial and dorsal root ganglia neurons. Given that LPA and S1P exhibit a powerful neurite-retraction activity (Postma et al., 1996 , Tigyi et al., 1996 , it is temping to suggest that Lpp3 expression in these neuronal types might serve to counteract the retractogenic environment caused by such lipids, contributing to the axon outgrowth during mouse development. In support of this idea is the inability of Lpp3 deficient MN differentiated in vitro from ES cells to produce neurites (R. Sánchez and D. E-A in preparation).
As previously described, Lpp3 is expressed during embryonic development in several structures where complex signaling networks occur to ensure their proper development and patterning. These observations suggest that Lpp3 expression may play a key role in modulating/integrating multiple signaling pathways during development. This idea rests on the assumption of a precise control of its temporal and spatial expression in conjunction with an accurate regulation of its actions as an intracellular or as a plasma membrane-associated protein. Tissue specific inactivation of Ppap2b will help us to address the participation of Lpp3 in the various mentioned developmental processes. Likewise the reporter allele described in this paper will allow us to address some aspects of the transcriptional regulation of Ppap2b during development.
Materials and Methods

Generation of Ppap2 tm2Stw ES cells and mice
The mouse EST AA276423 IMAGE Consortium clone ID 776179 (Lennon et al., 1996) was used to screen a 129/SvJ mouse genomic BAC library (Research Genetics). From clone BJ4123, a 5.1 XmaI fragment, containing exons 3 and 4, was used to produce an insertion targeting vector with the following configuration: 3 stop codons in 3 frames were introduced upstream of an IRES-lacZ reporter cassette. A PGKneo cassette, flanked by loxP sites, was introduced downstream of the reporter cassette for positive selection. The reporter-positive selection cassette was introduced in the proper orientation into the unique MunI restriction site located in exon 3. This insertion interrupts the protein between C1 and C2 domains essential for the catalytic activity. A TK negative selection cassette was added downstream of the 3' arm and then the vector linearized. W9.5 ES cells were electroporated with the targeting construct selected in the presence of G418 and FIAU and screened for legitimate homologous recombination by Southern (Fig.1) . The insertion of the reporter cassette introduces two additional BamHI sites, originating bands of 5.7 or 8.3 kb when using the 5' and 3' probes respectively, in BamHI digested genomic DNA. Out of 117 isolated clones, 24% resulted in the recombined allele. After karyotyping, one clone was selected for derivation of chimeras that were crossed to C57BL6/J females to test germ line transmission and to establish a mouse line designated Ppap2b tm2Stw .
Genotyping
For PCR genotyping, a set of three oligonucleotides was designed to distinguish between the wild type and targeted alleles. Primer a is upstream (a. 5' CTG TGC CAT TAG CCA GTC CTT CAC 3') and primer b is downstream (b. 5' TAG TTC TGA ATG TAG CCC TCG GAG 3') of the MunI restriction site fragment in exon 3. In the wild type configuration, these amplify a product of 128 bp. A primer in the floxed PGKneo cassette (c. 5' TTC TAT CGC CTT CTT GAC GAG TTC 3') in combination with primer b amplifies a product of around 700 bp. Alternatively born heterozygous individuals were genotyped using lacZ specific primers or β-galactosidase staining of ear fragments. β β β β β-galactosidase staining Embryos or fragments of tissues were stained as previously described (Hogan et al., 1994) . Briefly, tissues were immersed in fixative solution, washed 3 times for 30 min with detergent rinse and then incubated overnight in staining solution. The samples were embedded in paraffin, sectioned at 6 µm. Sections were visualized and photographed using Nomarski optics (DIC) or dark field illumination in which β-gal staining appeared of pink or reddish color.
Whole mount in situ hybridization
Mouse embryos were fixed and processed for in situ hybridization as described previously (Hogan et al., 1994) . Full length Lpp3 cDNA was cloned into pBluescript(KS) and then linearized with MunI. Anti-sense and sense probes were transcribed using T3 and T7 RNA polymerases respectively.
Whole mount immunohistochemistry
Protein detection was performed as previously described (Hogan et al., 1994) . Briefly, embryos were fixed with methanol/DMSO (4:1) and endogenous peroxidase activity was blocked by H 2 O 2 treatment. The incubation with the primary antibody (anti-LPP3, 1:200 Upstate) was carried out overnight at 4˚C. Anti-rabbit coupled to peroxidase was used at a dilution of 1:500. After color reaction embryos were post fixed with 4% paraformaldehyde and cleared with BABB for observation and photographic record.
